These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 16247643

  • 1. Phosphodiesterase inhibitors in female sexual dysfunction.
    Mayer M, Stief CG, Truss MC, Uckert S.
    World J Urol; 2005 Dec; 23(6):393-7. PubMed ID: 16247643
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction.
    Uckert S, Küthe A, Stief CG, Jonas U.
    World J Urol; 2001 Feb; 19(1):14-22. PubMed ID: 11289565
    [Abstract] [Full Text] [Related]

  • 4. Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues.
    Uckert S, Ellinghaus P, Albrecht K, Jonas U, Oelke M.
    J Sex Med; 2007 Nov; 4(6):1604-9. PubMed ID: 17888073
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
    Rosen RC, McKenna KE.
    Annu Rev Sex Res; 2002 Nov; 13():36-88. PubMed ID: 12836729
    [Abstract] [Full Text] [Related]

  • 7. Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries--immunohistochemical distribution and functional significance.
    Waldkirch E, Uckert S, Yildirim H, Sohn M, Jonas U, Stief CG, Andersson KE, Hedlund P.
    World J Urol; 2005 Dec; 23(6):405-10. PubMed ID: 16292559
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST.
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [Abstract] [Full Text] [Related]

  • 9. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
    Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C.
    Int J Impot Res; 1996 Jun; 8(2):47-52. PubMed ID: 8858389
    [Abstract] [Full Text] [Related]

  • 10. Phosphodiesterase inhibitors in the treatment of erectile dysfunction.
    Stief CG.
    Drugs Today (Barc); 2000 Jun; 36(2-3):93-9. PubMed ID: 12879106
    [Abstract] [Full Text] [Related]

  • 11. Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention.
    Montorsi F, Corbin J, Phillips S.
    J Sex Med; 2004 Nov; 1(3):322-36. PubMed ID: 16422964
    [Abstract] [Full Text] [Related]

  • 12. Oral phosphodiesterase type 5 inhibitors: nonerectogenic beneficial uses.
    Mostafa T.
    J Sex Med; 2008 Nov; 5(11):2502-18. PubMed ID: 18761597
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract.
    Uckert S, Kuczyk MA.
    Handb Exp Pharmacol; 2011 Nov; (202):527-42. PubMed ID: 21290241
    [Abstract] [Full Text] [Related]

  • 15. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?
    Chivers ML, Rosen RC.
    J Sex Med; 2010 Feb; 7(2 Pt 2):858-72. PubMed ID: 19929916
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.